Irsyad Adam

Irsyad develops novel architectures for LLM understanding of biological systems. He has created multi-modal graph deep learning pipelines and KG-LLM architectures for diagnosis, biomarker selection, and therapeutics in cardiovascular disease and NSCLC & COVID-19 clinical trials. Irsyad has previously built multi-modal AI pipelines for Genentech, AbbVie, the NIH, and the US Department of Defense.